Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome

British Journal of Surgery

Volumn 96, Issue 5, 2009, Pages 517-521

  Sward C ^a   Johanson, V ^a   Nieveen Van Dijkum, E ^a   Jansson, S ^a   Nilsson, O ^a   Wangberg B ^a   Ahlman, H ^a   Kolby L ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CHROMOGRANIN A;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GASTROINTESTINAL TUMOR; HEPATIC ARTERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDGUT; MIDGUT CARCINOID SYNDROME; MORTALITY; PRIORITY JOURNAL; SURVIVAL; CARCINOID; INTESTINE TUMOR; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 65249174468     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6587     Document Type: Article

References (27)

1. Cho KJ, Reuter SR, Schmidt R. Effects of experimental hepatic artery embolization on hepatic function. AJR Am J Roentgenol 1976; 127: 563-567.
2. Markowitz J, Lotto W, Archibald J, Downie HG. Technique and effects of portacaval anastomosis (Eck fistula). Surg Gynecol Obstet 1952; 95: 407-410.
3. Nilsson LA. Therapeutic hepatic artery ligation in patients with secondary liver tumors. Rev Surg 1966; 23: 374-376.
4. Chuang VP, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 1981; 140: 51-58.
5. Ajani JA, Carrasco CH, Wallace S. Neuroendocrine tumors metastatic to the liver. Vascular occlusion therapy. Ann N Y Acad Sci 1994; 733: 479-487.
6. Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J 2003; 9: 261-267.
7. Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000; 190: 432-445.
8. Coupe M, Levi S, Ellis M, Clarke B, Morris JA, Alstead EA et al. Therapy for symptoms in the carcinoid syndrome. Q J Med 1989; 73: 1021-1036.
9. Schell SR, Camp ER, Caridi JG, Hawkins IF Jr. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors. J Gastrointest Surg 2002; 6: 664-670.
10. Geterud K, Tylén U, Jansson S, Stenqvist O, Tisell L-E, Ahlman H. Hepatic arterial embolisation in the treatment of the midgut carcinoid syndrome and other advanced endocrine tumours metastatic to the liver. J Intervent Radiol 1990; 5: 69-76.
11. Wängberg B, Westberg G, Tylén U, Tisell L, Jansson S, Nilsson O et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 1996; 20: 892-899.
12. Jacobsen MB, Hanssen LE, Kolmannskog F, Schrumpf E, Vatn MH, Bergan A. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study. Scand J Gastroenterol 1995; 30: 789-796.
13. Mitty HA, Warner RR, Newman LH, Train JS, Parnes IH. Control of carcinoid syndrome with hepatic artery embolization. Radiology 1985; 155: 623-626.
14. Coldwell DM. Hepatic arterial embolization utilizing a coaxial catheter system: technical note. Cardiovasc Intervent Radiol 1990; 13: 53-54.
15. Chuang VP. Superselective hepatic tumour embolisation with Tracker-18 catheter. J Intervent Radiology 1988; 3: 69-71.
16. Cox DR, Oakes D. Analysis of Survival Data. Chapman & Hall: London, 1984.
17. Eriksson BK, Larsson EG, Skogseid BM, Löfberg AM, Lörelius LE, Oberg KE. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 1998; 83: 2293-2301.
18. Moertel CG, Johnson CM, McKusick MA, Martin JK Jr, Nagorney DM, Kvols LK et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994; 120: 302-309.
19. Drougas JG, Anthony LB, Blair TK, Lopez RR, Wright JK Jr, Chapman WC et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 1998; 175: 408-412.
20. Perry LJ, Stuart K, Stokes KR, Clouse ME. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery 1994; 116: 1111-1116.
21. Roche A, Girish BV, de Baère T, Baudin E, Boige V, Elias D et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003; 13: 136-140.
22. Ruszniewski P, Rougier P, Roche A, Legmann P, Sibert A, Hochlaf S et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 1993; 71: 2624-2630.
23. Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 2001; 130: 677-682.
24. McDermott EW, Guduric B, Brennan MF. Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg 1994; 81: 1007-1009.
25. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79: 813-829.
26. Moertel CG. Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1983; 1: 727-740.
27. Wängberg B, Ahlman H, Tylén U, Nilsson O, Hermodsson S, Hellstrand K. Accumulation of natural killer cells after hepatic artery embolisation in the midgut carcinoid syndrome. Br J Cancer 1995; 71: 617-618.